← World Watch
Disruptionother · July 14, 2026
Formycon and OneSource Specialty Pharma announce strategic partnership to manufacture biosimilars
A new manufacturing partnership expands biosimilar production capacity and could improve supply availability for those medicines.
Source →The trace
How it reaches your house.
Starting from the trigger, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
The causal trace for this event is still being written.